$11.30
-0.45 (-3.83%)
Open$11.63
Previous Close$11.75
Day High$11.84
Day Low$11.18
52W High$12.19
52W Low$4.82
Volume—
Avg Volume1.47M
Market Cap1.84B
P/E Ratio—
EPS$-1.01
SectorBiotechnology
Analyst Ratings
Strong Buy
14 analysts
Price Target
+50.3% upside
Current
$11.30
$11.30
Target
$16.98
$16.98
$13.41
$16.98 avg
$22.24
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 83.23M | 238.62M | 113.39M |
| Net Income | -531,763,437 | -1,372,096,024 | -30,823,495 |
| Profit Margin | -638.9% | -606.9% | -27.2% |
| EBITDA | -581,476,987 | -1,583,724,591 | -42,153,177 |
| Free Cash Flow | — | — | -22,930,380 |
| Rev Growth | -65.1% | -65.1% | +24.3% |
| Debt/Equity | — | — | 0.94 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $288.24 | -2.24% | 81.4 | 513.86B |
| AMGN | Amgen Inc | $460.28 | -3.80% | 28.5 | 249.09B |
| GILD | Gilead Sciences Inc | $167.57 | -3.96% | — | 212.04B |
| VRTX | Vertex Pharmaceuticals Inc | $542.50 | -1.19% | 30.6 | 134.77B |
| REGN | Regeneron Pharmaceuticals | $902.90 | -2.98% | 19.5 | 84.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.66 | -2.74% | 28.8 | 23.28B |